Taizhou Volsen Chemical Co., Ltd.
Home> Industry Information> Pralsetinib

Pralsetinib

January 15, 2024

Pralsetinib Pralsetinib cas number 2097132-94-8 ,also known as GAVRETO, is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. It is used to treat certain cancers caused by abnormal RET genes.iT is a targeted therapy that is taken by mouth once daily. 

The above is the Pralsetinib we have listed for you. You can submit the following form to obtain more industry information we provide for you.

You can visit our website or contact us, and we will provide the latest consultation and solutions

Share to:

Send Inquiry

Home> Industry Information> Pralsetinib
Related Products List

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send